Data / Form D filings / VistaGen Therapeutics, Inc.
VistaGen Therapeutics, Inc.: Form D filings
VistaGen Therapeutics, Inc., a pharmaceuticals company in South San Francisco, CA, filed 8 Form D notices with the SEC between 2012 and 2023. The latest, on February 21, 2023, reports an offering of $2.8 million with nothing sold yet to 129 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 343 Allerton Avenue, South San Francisco, CA, 94080
- Phone
- (650) 577-3600
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1411685
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | New notice | $2,798,415 | $0 | $2,798,415 | 129 | Feb 2, 2023 | sec.gov |
| Jan 31, 2020 | New notice | $2,750,000 | $2,750,000 | 3 | Jan 24, 2020 | sec.gov | |
| Dec 12, 2019 | New notice | $650,000 | $650,000 | 7 | Oct 30, 2019 | sec.gov | |
| Sep 21, 2018 | New notice | $5,750,000 | $4,778,750 | $971,250 | 33 | Jun 28, 2018 | sec.gov |
| Aug 22, 2017 | New notice | $1,037,750 | $1,037,750 | 14 | Mar 30, 2017 | sec.gov | |
| Aug 6, 2015 | New notice | $10,000,000 | $1,930,281 | $8,069,719 | 15 | May 26, 2015 | sec.gov |
| Jun 30, 2014 | New notice | $3,000,000 | $1,570,000 | $1,430,000 | 21 | Mar 14, 2014 | sec.gov |
| Mar 7, 2012 | New notice | $3,000,000 | $500,000 | $2,500,000 | 6 | Feb 28, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jerrold D. Dotson | Executive Officer | |
| Joanne M. Curley | Director | |
| Shawn K. Singh | Executive Officer, Director | |
| Jon S. Saxe | Director | |
| Jerry B. Gin | Director | |
| Ann M. Cunningham | Director | |
| Reid G. Adler | Executive Officer | |
| Margaret M. FitzPatrick | Director | |
| Mary L. Rotunno | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Feb 20, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what VistaGen Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.